1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Vulvar and Vaginal Atrophy Therapy Market, By Diagnosis
5.1 Introduction
5.2 Urine Test
5.3 Pelvic Examination
5.4 Acid Balance Test
6 Global Vulvar and Vaginal Atrophy Therapy Market, By Treatment
6.1 Introduction
6.2 Selective Estrogen Receptor Modulators
6.3 Non Hormonal Therapy
6.4 Laser Therapy
6.5 Hormonal Therapy
7 Global Vulvar and Vaginal Atrophy Therapy Market, By Indication
7.1 Introduction
7.2 Vaginal Dryness
7.3 Vaginal Burning
7.4 Vaginal Discharge
7.5 Genital Itching
7.6 Recurrent Urinary Tract Infections
7.7 Urinary Incontinence
7.8 Light Bleeding After Intercourse
7.9 Discomfort with Intercourse
7.10 Decreased Vaginal Lubrication During Sexual Activity
7.11 Shortening and Tightening of the Vaginal Canal
7.12 Burning Sensation in the Vagina
7.13 Dyspareunia
7.14 Urinary Tract Infection
8 Global Vulvar and Vaginal Atrophy Therapy Market, By End User
8.1 Hospitals
8.2 Ambulatory Surgical Centers
8.3 Specialty Clinics
9 Global Vulvar and Vaginal Atrophy Therapy Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Viveve, Inc.
11.2 VenusConcept
11.3 ThermiGen LLC
11.4 TherapeuticsMD, Inc.
11.5 Lutronic
11.6 Hologic
11.7 Fotona
11.8 BTL Group of Companies
11.9 Almirall
11.10 Alma Lasers
11.11 Sinclair
List of Tables
Table 1 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Region (2020-2028) (US $MN)
Table 2 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Diagnosis (2020-2028) (US $MN)
Table 3 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urine Test (2020-2028) (US $MN)
Table 4 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Pelvic Examination (2020-2028) (US $MN)
Table 5 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Acid Balance Test (2020-2028) (US $MN)
Table 6 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Treatment (2020-2028) (US $MN)
Table 7 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Selective Estrogen Receptor Modulators (2020-2028) (US $MN)
Table 8 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Non Hormonal Therapy (2020-2028) (US $MN)
Table 9 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Laser Therapy (2020-2028) (US $MN)
Table 10 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hormonal Therapy (2020-2028) (US $MN)
Table 11 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Indication (2020-2028) (US $MN)
Table 12 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Dryness (2020-2028) (US $MN)
Table 13 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Burning (2020-2028) (US $MN)
Table 14 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Discharge (2020-2028) (US $MN)
Table 15 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Genital Itching (2020-2028) (US $MN)
Table 16 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Recurrent Urinary Tract Infections (2020-2028) (US $MN)
Table17 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Incontinence (2020-2028) (US $MN)
Table 18 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Light Bleeding After Intercourse (2020-2028) (US $MN)
Table 19 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Discomfort with Intercourse (2020-2028) (US $MN)
Table 20 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Decreased Vaginal Lubrication During Sexual Activity (2020-2028) (US $MN)
Table 21 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Shortening and Tightening of the Vaginal Canal (2020-2028) (US $MN)
Table 22 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Burning Sensation in the Vagina (2020-2028) (US $MN)
Table 23 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Dyspareunia (2020-2028) (US $MN)
Table 24 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Tract Infection (2020-2028) (US $MN)
Table 25 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By End User (2020-2028) (US $MN)
Table 26 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hospitals (2020-2028) (US $MN)
Table 27 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Ambulatory Surgical Centers (2020-2028) (US $MN)
Table 28 Global Vulvar and Vaginal Atrophy Therapy Market Outlook, By Specialty Clinics (2020-2028) (US $MN)
Table 29 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Country (2020-2028) (US $MN)
Table 30 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Diagnosis (2020-2028) (US $MN)
Table 31 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urine Test (2020-2028) (US $MN)
Table 32 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Pelvic Examination (2020-2028) (US $MN)
Table 33 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Acid Balance Test (2020-2028) (US $MN)
Table 34 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Treatment (2020-2028) (US $MN)
Table 35 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Selective Estrogen Receptor Modulators (2020-2028) (US $MN)
Table 36 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Non Hormonal Therapy (2020-2028) (US $MN)
Table 37 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Laser Therapy (2020-2028) (US $MN)
Table 38 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hormonal Therapy (2020-2028) (US $MN)
Table 39 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Indication (2020-2028) (US $MN)
Table 40 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Dryness (2020-2028) (US $MN)
Table 41 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Burning (2020-2028) (US $MN)
Table 42 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Discharge (2020-2028) (US $MN)
Table 43 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Genital Itching (2020-2028) (US $MN)
Table 44 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Recurrent Urinary Tract Infections (2020-2028) (US $MN)
Table 45 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Incontinence (2020-2028) (US $MN)
Table 46 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Light Bleeding After Intercourse (2020-2028) (US $MN)
Table 47 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Discomfort with Intercourse (2020-2028) (US $MN)
Table 48 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Decreased Vaginal Lubrication During Sexual Activity (2020-2028) (US $MN)
Table 49 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Shortening and Tightening of the Vaginal Canal (2020-2028) (US $MN)
Table 50 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Burning Sensation in the Vagina (2020-2028) (US $MN)
Table 51 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Dyspareunia (2020-2028) (US $MN)
Table 52 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Tract Infection (2020-2028) (US $MN)
Table 53 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By End User (2020-2028) (US $MN)
Table 54 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hospitals (2020-2028) (US $MN)
Table 55 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Ambulatory Surgical Centers (2020-2028) (US $MN)
Table 56 North America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Specialty Clinics (2020-2028) (US $MN)
Table 57 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Country (2020-2028) (US $MN)
Table 58 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Diagnosis (2020-2028) (US $MN)
Table 59 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urine Test (2020-2028) (US $MN)
Table 60 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Pelvic Examination (2020-2028) (US $MN)
Table 61 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Acid Balance Test (2020-2028) (US $MN)
Table 62 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Treatment (2020-2028) (US $MN)
Table 63 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Selective Estrogen Receptor Modulators (2020-2028) (US $MN)
Table 64 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Non Hormonal Therapy (2020-2028) (US $MN)
Table 65 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Laser Therapy (2020-2028) (US $MN)
Table 66 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hormonal Therapy (2020-2028) (US $MN)
Table 67 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Indication (2020-2028) (US $MN)
Table 68 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Dryness (2020-2028) (US $MN)
Table 69 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Burning (2020-2028) (US $MN)
Table 70 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Discharge (2020-2028) (US $MN)
Table 71 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Genital Itching (2020-2028) (US $MN)
Table 72 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Recurrent Urinary Tract Infections (2020-2028) (US $MN)
Table 73 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Incontinence (2020-2028) (US $MN)
Table 74 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Light Bleeding After Intercourse (2020-2028) (US $MN)
Table 75 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Discomfort with Intercourse (2020-2028) (US $MN)
Table 76 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Decreased Vaginal Lubrication During Sexual Activity (2020-2028) (US $MN)
Table 77 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Shortening and Tightening of the Vaginal Canal (2020-2028) (US $MN)
Table 78 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Burning Sensation in the Vagina (2020-2028) (US $MN)
Table 79 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Dyspareunia (2020-2028) (US $MN)
Table 80 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Tract Infection (2020-2028) (US $MN)
Table 81 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By End User (2020-2028) (US $MN)
Table 82 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hospitals (2020-2028) (US $MN)
Table 83 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Ambulatory Surgical Centers (2020-2028) (US $MN)
Table 84 Europe Vulvar and Vaginal Atrophy Therapy Market Outlook, By Specialty Clinics (2020-2028) (US $MN)
Table 85 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Country (2020-2028) (US $MN)
Table 86 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Diagnosis (2020-2028) (US $MN)
Table 87 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urine Test (2020-2028) (US $MN)
Table 88 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Pelvic Examination (2020-2028) (US $MN)
Table 89 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Acid Balance Test (2020-2028) (US $MN)
Table 90 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Treatment (2020-2028) (US $MN)
Table 91 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Selective Estrogen Receptor Modulators (2020-2028) (US $MN)
Table 92 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Non Hormonal Therapy (2020-2028) (US $MN)
Table 93 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Laser Therapy (2020-2028) (US $MN)
Table 94 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hormonal Therapy (2020-2028) (US $MN)
Table 95 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Indication (2020-2028) (US $MN)
Table 96 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Dryness (2020-2028) (US $MN)
Table 97 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Burning (2020-2028) (US $MN)
Table 98 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Discharge (2020-2028) (US $MN)
Table 99 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Genital Itching (2020-2028) (US $MN)
Table 100 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Recurrent Urinary Tract Infections (2020-2028) (US $MN)
Table 101 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Incontinence (2020-2028) (US $MN)
Table 102 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Light Bleeding After Intercourse (2020-2028) (US $MN)
Table 103 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Discomfort with Intercourse (2020-2028) (US $MN)
Table 104 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Decreased Vaginal Lubrication During Sexual Activity (2020-2028) (US $MN)
Table 105 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Shortening and Tightening of the Vaginal Canal (2020-2028) (US $MN)
Table 106 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Burning Sensation in the Vagina (2020-2028) (US $MN)
Table 107 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Dyspareunia (2020-2028) (US $MN)
Table 108 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Tract Infection (2020-2028) (US $MN)
Table 109 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By End User (2020-2028) (US $MN)
Table 110 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hospitals (2020-2028) (US $MN)
Table 111 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Ambulatory Surgical Centers (2020-2028) (US $MN)
Table 112 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market Outlook, By Specialty Clinics (2020-2028) (US $MN)
Table 113 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Country (2020-2028) (US $MN)
Table 114 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Diagnosis (2020-2028) (US $MN)
Table 115 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urine Test (2020-2028) (US $MN)
Table 116 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Pelvic Examination (2020-2028) (US $MN)
Table 117 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Acid Balance Test (2020-2028) (US $MN)
Table 118 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Treatment (2020-2028) (US $MN)
Table 119 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Selective Estrogen Receptor Modulators (2020-2028) (US $MN)
Table 120 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Non Hormonal Therapy (2020-2028) (US $MN)
Table 121 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Laser Therapy (2020-2028) (US $MN)
Table 122 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hormonal Therapy (2020-2028) (US $MN)
Table 123 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Indication (2020-2028) (US $MN)
Table 124 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Dryness (2020-2028) (US $MN)
Table 125 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Burning (2020-2028) (US $MN)
Table 126 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Discharge (2020-2028) (US $MN)
Table 127 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Genital Itching (2020-2028) (US $MN)
Table 128 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Recurrent Urinary Tract Infections (2020-2028) (US $MN)
Table 129 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Incontinence (2020-2028) (US $MN)
Table 130 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Light Bleeding After Intercourse (2020-2028) (US $MN)
Table 131 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Discomfort with Intercourse (2020-2028) (US $MN)
Table 132 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Decreased Vaginal Lubrication During Sexual Activity (2020-2028) (US $MN)
Table 133 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Shortening and Tightening of the Vaginal Canal (2020-2028) (US $MN)
Table 134 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Burning Sensation in the Vagina (2020-2028) (US $MN)
Table 135 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Dyspareunia (2020-2028) (US $MN)
Table 136 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Tract Infection (2020-2028) (US $MN)
Table 137 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By End User (2020-2028) (US $MN)
Table 138 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hospitals (2020-2028) (US $MN)
Table 139 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Ambulatory Surgical Centers (2020-2028) (US $MN)
Table 140 South America Vulvar and Vaginal Atrophy Therapy Market Outlook, By Specialty Clinics (2020-2028) (US $MN)
Table 141 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Country (2020-2028) (US $MN)
Table 142 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Diagnosis (2020-2028) (US $MN)
Table 143 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urine Test (2020-2028) (US $MN)
Table 144 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Pelvic Examination (2020-2028) (US $MN)
Table 145 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Acid Balance Test (2020-2028) (US $MN)
Table 146 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Treatment (2020-2028) (US $MN)
Table 147 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Selective Estrogen Receptor Modulators (2020-2028) (US $MN)
Table 148 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Non Hormonal Therapy (2020-2028) (US $MN)
Table 149 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Laser Therapy (2020-2028) (US $MN)
Table 150 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hormonal Therapy (2020-2028) (US $MN)
Table 151 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Indication (2020-2028) (US $MN)
Table 152 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Dryness (2020-2028) (US $MN)
Table 153 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Burning (2020-2028) (US $MN)
Table 154 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Vaginal Discharge (2020-2028) (US $MN)
Table 155 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Genital Itching (2020-2028) (US $MN)
Table 156 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Recurrent Urinary Tract Infections (2020-2028) (US $MN)
Table 157 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Incontinence (2020-2028) (US $MN)
Table 158 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Light Bleeding After Intercourse (2020-2028) (US $MN)
Table 159 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Discomfort with Intercourse (2020-2028) (US $MN)
Table 160 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Decreased Vaginal Lubrication During Sexual Activity (2020-2028) (US $MN)
Table 161 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Shortening and Tightening of the Vaginal Canal (2020-2028) (US $MN)
Table 162 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Burning Sensation in the Vagina (2020-2028) (US $MN)
Table 163 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Dyspareunia (2020-2028) (US $MN)
Table 164 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Urinary Tract Infection (2020-2028) (US $MN)
Table 165 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By End User (2020-2028) (US $MN)
Table 166 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Hospitals (2020-2028) (US $MN)
Table 167 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Ambulatory Surgical Centers (2020-2028) (US $MN)
Table 168 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Outlook, By Specialty Clinics (2020-2028) (US $MN)
| ※参考情報 外陰部および膣萎縮症は、女性の生殖器系における一連の症状で、主に更年期や加齢によって引き起こされます。この状態は、膣の粘膜が薄くなり、水分が失われることによって生じ、性行為時の疼痛や不快感、かゆみ、排尿時の不快感などを伴います。これらの症状は患者のQOL（生活の質）を大きく損ねることがあります。 外陰部および膣萎縮症の治療法はいくつか存在し、患者の症状や状態に応じて選択されます。まず代表的な治療法としてホルモン療法があります。特にエストロゲンに基づく治療は、膣の細胞を刺激して再生させ、潤いを正常に取り戻す効果があります。局所的なエストロゲン療法は、膣錠、クリーム、パッチなどの形で使用され、全身的な副作用を最小限に抑えながらターゲットを絞った治療が可能です。 また、非ホルモン療法も選択肢として存在します。潤滑剤や保湿剤は性行為時の摩擦を軽減し、日常生活における不快感を和らげることができます。これらは医療機関で処方されるものだけでなく、市販のものも多く存在します。さらに、膣の健康を維持するためのサプリメントなども利用されることがあります。 最近ではレーザー治療も注目されています。CO2レーザーやYAGレーザーを用いた治療法は、膣の組織を刺激してコラーゲンの生成を促進し、潤滑性を改善します。この方法は痛みが少なく、回復が早いという利点があります。ただし、実施する際は信頼性の高い医療機関で行うことが重要です。 さらに、膣萎縮症に関連する症状や患者の生活の質を向上させるための行動療法やカウンセリングも有効です。心理的なストレスや教育が正しく行われない場合、治療の効果が薄れる可能性があるため、これらのサポートを取り入れることは非常に重要です。 また、生活習慣の見直しも重要です。適度な運動やバランスの取れた食事は、ホルモンバランスを維持し、外陰部および膣の健康を促進することにつながります。特に、充分な水分摂取は体全体の潤いを保つためにも有効です。 外陰部および膣萎縮症は、非常に多くの女性が経験する可能性がある問題であり、そのため十分な理解と対策が求められます。早期の診断と適切な治療を受けることが、症状の悪化を防ぎ、快適な生活を取り戻すために不可欠です。これらの治療法やアプローチが適切に行われることによって、多くの女性が症状を和らげ、日常生活をより楽しむことができるようになるでしょう。 診療においては、それぞれの女性の状況に応じてオーダーメイドの治療計画が立てられるべきです。そのためには、医師との十分なコミュニケーションが必要ですし、患者自身も自分の状態に対して理解を深めることが重要です。これにより不安や悩みを和らげ、治療に対するアプローチがより前向きなものになるでしょう。 外陰部および膣萎縮症は、一見するとデリケートなテーマですが、女性の健康を守るためには重要な課題です。知識を深め、適切な情報を得ることで、自身の健康を守る手助けとなるでしょう。健康な生活を送るために、必要な治療法やサポートを見つけ出し、生活の質を向上させる努力を続けていくことが求められます。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
